Alcohol
Volume 27, Issue 1 , Pages 29-36 , May 2002

Lymphocyte recruitment to the liver in alcoholic liver disease

Received 23 November 2001 ,Revised 22 January 2002 ,Accepted 3 February 2002.

References 

  1. Adams DH. Leucocyte adhesion molecules and alcoholic liver disease. Alcohol Alcohol. 1994;29:249–260
  2. Adams DH, Burra P, Hubscher SG, Elias E, Newman W. Endothelial activation and circulating vascular adhesion molecules in alcoholic liver disease. Hepatology. 1994;19:588–594
  3. Adams DH, Hubscher SG, Fisher NC, Williams A, Robinson M. Expression of E-selectin and E-selectin ligands in human liver inflammation. Hepatology. 1996;24:533–538
  4. Adams DH, Shaw S. Leucocyte–endothelial interactions and regulation of leucocyte migration. Lancet. 1994;343:831–836
  5. Afford SC, Fisher NC, Neil DAH, Fear J, Brun P, Hubscher SG, et al. Distinct patterns of chemokine expression are associated with leukocyte recruitment in alcoholic hepatitis and alcoholic cirrhosis. J Pathol. 1998;186:82–89
  6. Alon R, Kassner PD, Carr MW, Finger EB, Hemler ME, Springer TA. The integrin VLA-4 supports tethering and rolling in flow on VCAM-1. J Cell Biol. 1995;128:1243–1253
  7. Batey RG, Clancy RL, Pang GT, Cao Q. Alcoholic hepatitis as a T-cell mediated disorder (an hypothesis). Alcohol Clin Exp Res. 1999;23:1207–1209
  8. Berlin C, Berg EL, Briskin MJ, Andrew DP, Kilshaw PJ, Holzmann B, et al. Alpha 4 beta 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell. 1993;74:185–195
  9. Berman ME, Xie Y, Muller WA. Roles of platelet/endothelial cell adhesion molecule-1 (PECAM-1, CD31) in natural killer cell transendothelial migration and beta 2 integrin activation. J Immunol. 1996;156:1515–1524
  10. Bird IN, Spragg JH, Ager A, Matthews N. Studies of lymphocyte transendothelial migration (analysis of migrated cell phenotypes with regard to CD31 (PECAM-1), CD45RA and CD45RO). Immunology. 1993;80:553–560
  11. Bogen SA, Baldwin HS, Watkins SC, Albelda SM, Abbas AK. Association of murine CD31 with transmigrating lymphocytes following antigenic stimulation. Am J Pathol. 1992;141:843–854
  12. Bradham CA, Plumpe J, Manns MP, Brenner DA, Trautwein C. Mechanisms of hepatic toxicity. I. TNF-induced liver injury. Am J Physiol. 1998;275:G387–G392
  13. Briskin M, Winsor-Hines D, Shyjan A, Cochran N, Bloom S, Wilson J, et al. Human mucosal addressin cell adhesion molecule-1 is preferentially expressed in intestinal tract and associated lymphoid tissue. Am J Pathol. 1997;151:97–110
  14. Burra P, Hubscher SG, Shaw J, Elias E, Adams DH. Is the ICAM-1/LFA-1 pathway of leucocyte adherence involved in the hepatocyte damage of alcoholic hepatitis?. Gut. 1992;33:268–271
  15. Butcher EC, Picker LJ. Lymphocyte homing and homeostasis. Science. 1996;272:60–66
  16. Butcher EC, Williams M, Youngman K, Rott L, Briskin M. Lymphocyte trafficking and regional immunity. Adv Immunol. 1999;72:209–253
  17. Campbell JJ, Butcher EC. Chemokines in tissue-specific and microenvironment-specific lymphocyte homing. Curr Opin Immunol. 2000;12:336–341
  18. Campbell JJ, Haraldsen G, Pan J, Rottman J, Qin S, Ponath P, et al. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature. 1999;400:776–780
  19. Campbell JJ, Qin SX, Bacon KB, Mackay CR, Butcher EC. Biology of chemokine and classical chemoattractant receptors (differential requirements for adhesion-triggering versus chemotactic responses in lymphoid cells). J Cell Biol. 1996;134:255–266
  20. Chedid A, Mendenhall CL, Moritz TE, French SW, Chen TS, Morgan TR, et al. Cell-mediated hepatic injury in alcoholic liver disease. Veterans Affairs Cooperative Study Group 275. Gastroenterology. 1993;105:254–266
  21. Cinamon G, Shinder V, Alon R. Shear forces promote lymphocyte migration across vascular endothelium bearing apical chemokines. Nat Immunol. 2001;2:515–522
  22. Crispe IN, Dao T, Klugewitz K, Mehal WZ, Metz DP. The liver as a site of T-cell apoptosis (graveyard, or killing field?). Immunol Rev. 2000;174:47–62
  23. Day CP. Who gets alcoholic liver disease (nature or nurture?). J R Coll Physicians Lond. 2000;34:557–562
  24. Doherty DG, Norris S, Madrigal-Estebas L, McEntee G, Traynor O, Hegarty JE, et al. The human liver contains multiple populations of NK cells, T cells, and CD3+CD56+ natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns. J Immunol. 1999;163:2314–2321
  25. Doherty DG, O'Farrelly C. Innate and adaptive lymphoid cells in the human liver. Immunol Rev. 2000;174:5–20
  26. Faint JM, Annels NE, Curnow SJ, Shields P, Pilling D, Hislop AD, et al. Memory T cells constitute a subset of the human CD8+CD45RA+ pool with distinct phenotypic and migratory characteristics. J Immunol. 2001;167:212–220
  27. Fisher NC, Afford SC, Adams DH. Adhesion molecules and alcoholic liver disease. Hepatogastroenterology. 1996;43:1113–1116
  28. Fisher NC, Neil DA, Williams A, Adams DH. Serum concentrations and peripheral secretion of the beta chemokines monocyte chemoattractant protein 1 and macrophage inflammatory protein 1alpha in alcoholic liver disease. Gut. 1999;45:416–420
  29. French SW, Nash J, Shitabata P, Kachi K, Hara C, Chedid A, et al. Pathology of alcoholic liver disease. VA Cooperative Group 119. Semin Liver Dis. 1993;13:154–169
  30. Galle PR, Hofmann WJ, Walczak H, Schaller H, Otto G, Stremmel W, et al. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med. 1995;182:1223–1230
  31. Galle PR, Krammer PH. CD95-induced apoptosis in human liver disease. Semin Liver Dis. 1998;18:141–151
  32. Goddard S, Williams A, Morland C, Qin S, Gladue R, Hubscher SG, et al. Differential expression of chemokines and chemokine receptors shapes the inflammatory response in rejecting human liver transplants. Transplantation. 2001;72:1957–1967
  33. Hamann A, Klugewitz K, Austrup F, Jablonski-Westrich D. Activation induces rapid and profound alterations in the trafficking of T cells. Eur J Immunol. 2000;30:3207–3218
  34. Hogaboam CM, Bone-Larson CL, Steinhauser ML, Lukacs NW, Colletti LM, Simpson KJ, et al. Novel CXCR2-dependent liver regenerative qualities of ELR-containing CXC chemokines. FASEB J. 1999;13:1565–1574
  35. Hubscher SG. Histological grading and staging in chronic hepatitis (clinical applications and problems). J Hepatol. 1998;29:1015–1022
  36. International Group . Alcoholic liver disease (morphological manifestations). Lancet. 1981;1:707–711
  37. Jaeschke H, Smith CW. Cell adhesion and migration. III. Leukocyte adhesion and transmigration in the liver vasculature. Am J Physiol. 1997;273:G1169–G1173
  38. Kim CH, Kunkel EJ, Boisvert J, Johnston B, Campbell JJ, Genovese MC, et al. Bonzo/CXCR6 expression defines type 1–polarized T-cell subsets with extralymphoid tissue homing potential. J Clin Invest. 2001;107:595–601
  39. Knolle PA, Gerken G. Local control of the immune response in the liver. Immunol Rev. 2000;174:21–34
  40. Kunkel EJ, Campbell JJ, Haraldsen G, Pan J, Boisvert J, Roberts AI, et al. Lymphocyte CC chemokine receptor 9 and epithelial thymus-expressed chemokine (TECK) expression distinguish the small intestinal immune compartment (epithelial expression of tissue-specific chemokines as an organizing principle in regional immunity). J Exp Med. 2000;192:761–768
  41. Kurkijarvi R, Adams DH, Leino R, Mottonen T, Jalkanen S, Salmi M. Circulating form of human vascular adhesion protein-1 (VAP-1) (increased serum levels in inflammatory liver diseases). J Immunol. 1998;161:1549–1557
  42. Kurkijarvi R, Yegutkin GG, Gunson BK, Jalkanen S, Salmi M, Adams DH. Circulating soluble vascular adhesion protein 1 accounts for the increased serum monoamine oxidase activity in chronic liver disease. Gastroenterology. 2000;119:1096–1103
  43. Lalor PF, Adams DH. Adhesion of lymphocytes to hepatic endothelium. Mol Pathol. 1999;52:214–219
  44. Lalor PF, Clements JM, Pigott R, Humphries MJ, Spragg JH, Nash GB. Association between receptor density, cellular activation, and transformation of adhesive behavior of flowing lymphocytes binding to VCAM-1. Eur J Immunol. 1997;27:1422–1426
  45. Lieber CS. Alcoholic liver disease (new insights in pathogenesis lead to new treatments). J Hepatol. 2000;32:113–128
  46. Lumeng L, Crabb DW. Genetic aspects and risk factors in alcoholism and alcoholic liver disease. Gastroenterology. 1994;107:572–588
  47. Maltby J, Wright S, Bird G, Sheron N. Chemokine levels in human liver homogenates (associations between GRO alpha and histopathological evidence of alcoholic hepatitis). Hepatology. 1996;24:1156–1160
  48. McNab G, Reeves JL, Salmi M, Hubscher SG, Jalkanen S, Adams DH. Vascular adhesion protein 1 mediates binding of T cells to human hepatic endothelium. Gastroenterology. 1996;110:522–528
  49. Mehal WZ, Juedes AE, Crispe IN. Selective retention of activated CD8+ T cells by the normal liver. J Immunol. 1999;163:3202–3210
  50. Morland CM, Fear J, McNab G, Joplin R, Adams DH. Promotion of leukocyte transendothelial cell migration by chemokines derived from human biliary epithelial cells in vitro. Proc Assoc Am Physicians. 1997;109:372–382
  51. Moser B, Loetscher P. Lymphocyte traffic control by chemokines. Nat Immunol. 2001;2:123–128
  52. Muller WA. The role of PECAM-1 (CD31) in leukocyte emigration (studies in vitro and in vivo). J Leukoc Biol. 1995;57:523–528
  53. Murdoch C, Finn A. Chemokine receptors and their role in inflammation and infectious diseases. Blood. 2000;95:3032–3043
  54. Narumi S, Tominaga Y, Tamaru M, Shimai S, Okumura H, Nishioji K, et al. Expression of IFN-inducible protein-10 in chronic hepatitis. J Immunol. 1997;158:5536–5544
  55. Narumi S, Yoneyama H, Inadera H, Nishioji K, Itoh Y, Okanoue T, et al. TNF-alpha is a potent inducer for IFN-inducible protein-10 in hepatocytes and unaffected by GM-CSF in vivo, in contrast to IL-1beta and IFN-gamma. Cytokine. 2000;12:1007–1016
  56. Ohkubo K, Masumoto T, Horiike N, Onji M. Induction of CINC (interleukin-8) production in rat liver by non-parenchymal cells. J Gastroenterol Hepatol. 1998;13:696–702
  57. Rowell DL, Eckmann L, Dwinell MB, Carpenter SP, Raucy JL, Yang SK, et al. Human hepatocytes express an array of proinflammatory cytokines after agonist stimulation or bacterial invasion. Am J Physiol. 1997;273:G322–G332
  58. Salmi M, Adams DH, Jalkanen S. Cell adhesion and migration. IV. Lymphocyte trafficking in the intestine and liver. Am J Physiol. 1998;274:G1–G6
  59. Salmi M, Jalkanen S. Human vascular adhesion protein 1 (VAP-1) is a unique sialoglycoprotein that mediates carbohydrate-dependent binding of lymphocytes to endothelial cells. J Exp Med. 1996;183:569–579
  60. Salmi M, Jalkanen S. How do lymphocytes know where to go (current concepts and enigmas of lymphoctye homing). Adv Immunol. 1997;64:139–218
  61. Salmi M, Tohka S, Berg EL, Butcher EC, Jalkanen S. Vascular adhesion protein 1 (VAP-1) mediates lymphocyte subtype-specific, selectin-independent recognition of vascular endothelium in human lymph nodes. J Exp Med. 1997;186:589–600
  62. Salminen TA, Nymalm Y, Kankare J, Kapyla J, Heino J, Johnson MS. Production, crystallization and preliminary X-ray analysis of the human integrin alpha1 I domain. Acta Crystallogr D Biol Crystallogr. 1999;55:1365–1367
  63. Scoazec J-Y, Durand F, Degott C, Delautier D, Bernuau J, Belghiti J, et al. Expression of cytokine-dependent adhesion molecules in postreperfusion biopsy specimens of liver allografts. Gastroenterology. 1994;107:1094–1102a
  64. Scoazec J-Y, Feldmann G. The cell adhesion molecules of hepatic sinusoidal endothelial cells. J Hepatol. 1994;20:296–300
  65. Scoazec J-Y, Flejou JF, D'Errico A, Couvelard A, Kozyraki R, Fiorentino M, et al. Focal nodular hyperplasia of the liver (composition of the extracellular matrix and expression of cell–cell and cell–matrix adhesion molecules). Hum Pathol. 1995;26:1114–1125
  66. Scoazec J-Y, Racine L, Couvelard A, Flejou JF, Feldmann G. Endothelial cell heterogeneity in the normal human liver acinus (in situ immunohistochemical demonstration). Liver. 1994;14:113–123b
  67. Sheron N, Bird G, Koskinas J, Portmann B, Ceska M, Lindley I, et al. Circulating and tissue levels of the neutrophil chemotaxin interleukin-8 are elevated in severe acute alcoholic hepatitis, and tissue levels correlate with neutrophil infiltration. Hepatology. 1993;18:41–46
  68. Shields PL, Morland CM, Salmon M, Qin S, Hubscher SG, Adams DH. Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C–infected liver. J Immunol. 1999;163:6236–6243
  69. Shoudai K, Hieshima K, Fukuda S, Iio M, Miura R, Imai T, et al. Isolation of cDNA encoding a novel human CC chemokine NCC-4/LEC. Biochim Biophys Acta. 1998;1396:273–277
  70. Sotsios Y, Ward SG. Phosphoinositide 3-kinase (a key biochemical signal for cell migration in response to chemokines). Immunol Rev. 2000;177:217–235
  71. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration (the multistep paradigm). Cell. 1994;76:301–314
  72. Steinhoff G, Behrend M, Schrader B, Duijvestijn AM, Wonigeit K. Expression patterns of leukocyte adhesion ligand molecules on human liver endothelia. Lack of ELAM-1 and CD62 inducibility on sinusoidal endothelia and distinct distribution of VCAM-1, ICAM-1, ICAM-2, and LFA-3. Am J Pathol. 1993;142:481–488a
  73. Steinhoff G, Behrend M, Schrader B, Pichlmayr R. Intercellular immune adhesion molecules in human liver transplants (overview on expression patterns of leukocyte receptor and ligand molecules). Hepatology. 1993;18:440–453b
  74. Taieb J, Mathurin P, Poynard T, Gougerot-Pocidalo MA, Chollet-Martin S. Raised plasma soluble Fas and Fas-ligand in alcoholic liver disease. Lancet. 1998;351:1930–1931
  75. Takasaki S, Hano H. Three-dimensional observations of the human hepatic artery (Arterial system in the liver). J Hepatol. 2001;34:455–466
  76. Tamaru M, Nishioji K, Kobayashi Y, Watanabe Y, Itoh Y, Okanoue T, et al. Liver-infiltrating T lymphocytes are attracted selectively by IFN-inducible protein-10. Cytokine. 2000;12:299–308
  77. Tanaka Y, Adams DH, Hubscher S, Hirano H, Siebenlist U, Shaw S. T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1β. Nature. 1993;361:79–82a
  78. Tanaka Y, Adams DH, Shaw S. Proteoglycans on endothelial cells present adhesion-inducing cytokines to leukocytes. Immunol Today. 1993;14:111–115b
  79. Tanaka Y, Kimata K, Adams DH, Eto S. Modulation of cytokine function by heparin sulfate proteoglycans (sophisticated models for the regulation of cellular responses to cytokines). Proc Assoc Am Physicians. 1998;110:118–125
  80. Tedder TF, Steeber DA, Chen A, Engel P. The selectins (vascular adhesion molecules). FASEB J. 1995;9:866–873
  81. Wang H, Gao X, Fukumoto S, Tademoto S, Sato K, Hirai K. Differential expression and regulation of chemokines JE, KC, and IP-10 gene in primary cultured murine hepatocytes. J Cell Physiol. 1999;181:361–370
  82. Warnock RA, Campbell JJ, Dorf ME, Matsuzawa A, McEvoy LM, Butcher EC. The role of chemokines in the microenvironmental control of T versus B cell arrest in Peyer's patch high endothelial venules. J Exp Med. 2000;191:77–88
  83. Wong J, Johnston B, Lee SS, Bullard DC, Smith CW, Beaudet AL, et al. A minimal role for selectins in the recruitment of leukocytes into the inflamed liver microvasculature. J Clin Invest. 1997;99:2782–2790
  84. Yoong KF, Afford SC, Jones R, Aujla P, Qin S, Price K, et al. Expression and function of CXC and CC chemokines in human malignant liver tumors (a role for human monokine induced by gamma-interferon in lymphocyte recruitment to hepatocellular carcinoma). Hepatology. 1999;30:100–111
  85. Yoong KF, McNab G, Hubscher SG, Adams DH. Vascular adhesion protein-1 and ICAM-1 support the adhesion of tumor-infiltrating lymphocytes to tumor endothelium in human hepatocellular carcinoma. J Immunol. 1998;160:3978–3988

☆ Editor: T.R. Jerrells

PII: S0741-8329(02)00208-2

Alcohol
Volume 27, Issue 1 , Pages 29-36 , May 2002

Article Tools